Total Price: $0.00
Contact Information
Recombinant Human GIP protein (His tag)
SKU: PDEH100174-100
To better serve you, we would like to discuss your specific requirement.
Please Contact Us for a quote.
Recombinant Human GIP protein (His tag)
| SKU # | PDEH100174 |
| Expression Host | E. coli |
Description
| Synonyms | gastric inhibitory polypeptide;GIP;Glucose-dependent Insulinotropic Polypeptide;Incretin |
| Species | Human |
| Expression_host | E.coli |
| Sequence | Glu 22-Arg 153 |
| Accession | P09681 |
| Mol_Mass | 14.41 kDa |
| AP_Mol_Mass | 18 kDa |
| Tag | N-His |
| Bio_Activity | Not validated for activity |
Properties
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Endotoxin level | Please contact us for more information. |
| Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
| Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
| Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Reconstitution | It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis |
Background
Gastric inhibitory polypeptide (GIP), also known as the glucose-dependent insulinotropic peptide is a member of the secretin family of hormones. GIP, together with glucagon-like peptide-1 (GLP-1), belongs to the group of metabolic hormones called incretins that stimulate a decrease in blood glucose levels. GIP is derived from a 153-amino acid pro-protein encoded by the GIP gene and circulates as a biologically active 42-amino acid peptide. Engagement of Gastric inhibitory polypeptide receptors (GIPR) by GIP on pancreatic beta cells activates adenylate cyclase to regulate insulin compensation in the presence of high circulating glucose.